Antibacterial Activity of Bacteriophage Lytic Enzyme Ply900

Yuan Li1, Luxiang Xu1, Yuhan Zhang1

  • 1College of Veterinary Medicine (Preventive Veterinary Medicine), Northeast Agricultural University, No. 600, Changjiang Road, Xiangfang District, Harbin 150030, China.

Veterinary Sciences
|January 28, 2026
PubMed

Insights

The bacteriophage lytic enzyme Ply900 effectively combats Streptococcus suis infections in mice, showing broad antibacterial activity and stability. This lysin offers a promising new strategy against multi-drug resistant bacterial pathogens.

Area of Science:

  • Microbiology
  • Bacteriophage Therapy
  • Antimicrobial Resistance

Background:

  • Streptococcus suis (S. suis) is a significant zoonotic pathogen causing severe diseases in both animals and humans.
  • The rise of multi-drug resistance (MDR) in bacteria necessitates the development of alternative antibacterial treatments.
  • Bacteriophage-derived lysins represent a promising class of antimicrobials.

Purpose of the Study:

  • To evaluate the antibacterial potential and therapeutic efficacy of the bacteriophage lytic enzyme Ply900 against S. suis.
  • To analyze the functional domains of Ply900 and elucidate its mechanism of action.
  • To assess the in vivo therapeutic dynamics and resistance development potential of Ply900.

Main Methods:

  • In vitro lytic activity assays against various bacterial strains.
  • Biochemical stability tests under different environmental conditions.
  • In vivo efficacy study using a mouse model of S. suis infection, including survival rate analysis.
  • Mechanistic analysis of Ply900's domain functions and key amino acid residues involved in cleavage.

Main Results:

  • Ply900 demonstrated potent lytic activity against S. suis, S. agalactiae, and S. aureus.
  • The enzyme exhibited broad biochemical stability, tolerating diverse conditions.
  • In vivo studies showed effective S. suis eradication and improved survival rates in infected mice.
  • No induced resistance to Ply900 was observed in the treated bacterial populations.
  • The SH3B and CHAP domains were identified as crucial for synergistic peptidoglycan binding and cleavage.

Conclusions:

  • Lysin Ply900 is a potent antibacterial agent with broad-spectrum activity and stability.
  • Ply900 demonstrates significant therapeutic potential for treating S. suis infections in vivo.
  • The enzyme's mechanism involves synergistic domain interactions, and no resistance was induced, highlighting its promise for clinical and agricultural applications.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.7K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.7K
Enzymes and Activation Energy01:13

Enzymes and Activation Energy

The activation energy (or free energy of activation), abbreviated as Ea, is the small amount of energy input necessary for all chemical reactions to occur. During chemical reactions, certain chemical bonds break, and new ones form. For example, when a glucose molecule breaks down, bonds between the molecule's carbon atoms break. Since these are energy-storing bonds, they release energy when broken. However, the molecule must be somewhat contorted to get into a state that allows the bonds to...
23.5K
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
94.6K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
959
Enzyme Kinetics01:19

Enzyme Kinetics

Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
104.0K